Restricting dietary fiber is a common advice for people living with inflammatory bowel disease. New research shows that not all fibers work the same and their impact on intestinal inflammation and gut barrier function depend on the type of fiber, individual immune status and the fermentative capacity of their gut microbes.
SEARCH
Study identifies a role for bacterial proteases in Crohn’s disease
26 Jun 2023by Amber Hann, Heather Galipeau
Inflammatory bowel disease is a chronic remitting and relapsing condition that causes severe inflammation of the intestines and disabling bowel symptoms. It affects millions of lives globally, and although alterations in the gut microbiome have been associated with IBD, precise mechanisms remain incompletely understood. New research from McMaster University now implicates bacterial proteases in Crohn’s disease.
Abstracts 2023 GMFH Summit 01 CLINICAL VALIDATION OF A FECAL BACTERIAL SIGNATURE TEST FOR COLORECTAL
Which dietary components should be promoted, and which ones should be limited in inflammatory bowel disease?
19 May 2023by GMFH Editing Team
What to eat or not to eat as a means of reducing IBD symptoms is one of the main queries a patient might have following diagnosis. Although there is no simple answer and dietary changes are not a substitute for medical therapy, to help consider this question, we have prepared a new infographic on the dietary components to promote and limit in patients with IBD.
The translational potential of microbiome research for human health and disease: takeaways from the 2023 GMFH Summit
28 Apr 2023by Andreu Prados, Joël Doré
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Fecal microbiota transplantation: From clinical trials to market, where are we now?
7 Feb 2023by Andreu Prados
While fecal microbiota transplants are recommended for multiple recurrent Clostridioides difficile infection, their use in clinical practice is hindered by a lack of regulation and understanding of the underlying ecological dynamics. This article covers major challenges for the treatment in transitioning from bench to bedside, from the scientific, clinical and regulatory perspectives (Part 6).
The role of the gut mycobiota in influencing the immune system and inflammation-related diseases
12 Jan 2023by Andreu Prados
Gut fungi found in the lower gastrointestinal tract can influence the host immune system just like the bacterial microbiota. This article focuses on the role of the gut mycobiota in immune system homeostasis and its relevance for host health.
In which circumstances is intestinal permeability increased and what can be done to improve it?
27 Dec 2022by Andreu Prados
A wide range of diseases, from irritable bowel syndrome to depression, have been associated with increased intestinal permeability or ‘leaky gut’. What does a leaky gut mean, how can it be diagnosed and what available dietary strategies work for managing it?
Speakers, moderators & chairs 2023 GMFH Summit Nicholas Arpaia Dr. Arpaia received a B.S. in
Program 2023 GMFH Summit All times are in local time - CET General Topic: “The
